Comparative risk assessment study of elemental impurities in Montelukast chewable tablets and film-coated tablets
It is well documented that elemental impurities (EIs) are critical in the field of pharmaceutical development since they could affect the quality, efficacy and safety of the finished dosage form (FDF). The responsibility of pharmaceutical manufacturers is to demonstrate via assessment approach, risk...
Saved in:
Main Authors: | Angelevski Stefan (Author), Slaveska-Spirevska Irena (Author), Lazarevska-Todevska Elena (Author), Bakovska-Stoimenova Tanja (Author), Glavaš-Dodov Marija (Author), Simonoska-Crcarevska Maja (Author), Slaveska-Raički Renata (Author) |
---|---|
Format: | Book |
Published: |
Pharmaceutical Association of Serbia, Belgrade, Serbia,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design of Experiments (DoE)-based approach for improvement of dry mixing processes in the production of low-dose Alprazolam tablets using Raman spectroscopy for content uniformity monitoring
by: Makraduli Liljana, et al.
Published: (2023) -
Quality use of an unlicensed medicine and off label use of a medicine
by: Vasilka Nicha, et al.
Published: (2014) -
Development of a Novel, Fast, Simple HPLC Method for Determination of Atorvastatin and its Impurities in Tablets
by: Nataliia Shulyak, et al.
Published: (2021) -
Pharmaceutical Equivalence of Film-Coated and Chewable Tablets: A Comparative Dissolution Study Using Pulverized Chewable Tablets
by: Suck-Yong Park, et al.
Published: (2024) -
Pharmacokinetics and Bioequivalence Evaluation of Two Montelukast Sodium Chewable Tablets in Healthy Chinese Volunteers Under Fasted and Fed Conditions
by: Li W, et al.
Published: (2021)